Clinical Trial Update: A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the MV-s-NAP vaccine for invasive, metastatic breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• MV-s-NAP

Snippet

Sponsor: Mayo Clinic | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma | Phase 1 | Status: RECRUITING